Effect of different types of coffee consumption on the risk of cardiovascular complications and related mortality events in prediabetes: an analysis from NHANES
Yang D, Mao Y, Chen S, et al.
Nutr Metab Cardiovasc Dis. Pub. online 8 May 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Influence of glucagon-like peptide-1 receptor agonists on renal parameters: a meta-analysis of randomized controlled trials
Li W, Liang X, Sun N, Zhang D
BMC Endocr Disord. 2025;25(1):124.
Leggi
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
Bensaaud A, Seery S, Gibson I, et al.
Cochrane Database Syst Rev. 2025;5(5):CD013729.
Abstract
Leggi
Cellular versus acellular matrix products for diabetic foot ulcer treatment: the Dermagraft and Oasis Longitudinal Comparative Efficacy Study (DOLCE) – a randomized clinical trial
Shawa H, Kaur R, Tchanque-Fossuo C, et al.
Diabetes Care. 2025:dc241233.
Leggi
The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status
Zhai W, Zhang G, Wei C, et al.
Diabetes Obes Metab. Pub. online 2 May 2025.
Leggi
Aetiology of type 2 diabetes: an experimental medicine odyssey
Taylor R
Diabetologia. Pub. online 2 May 2025.
Leggi
Duration and type of statin use and long-term risk of type 2 diabetes among men and women with hypercholesterolaemia: findings from three prospective cohorts
Zhang Y, Li Y, Liu Y, et al.
Diabetologia. Pub. online 2 May 2025.
Leggi
Long-term effects of metformin on offspring health: a review of current evidence and future directions
Mayadunne T, Saadati S, Asmelash D, Mason T, et al.
Diabetes Obes Metab. Pub. online 6 May 2025.
Leggi
Comparative efficacy and safety of SGLT2 inhibitor class members in patients with heart failure and type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
Su AY, Csere MM, Shan R, et al.
Diabetes Res Clin Pract. 2025:112219.
Leggi
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: an indirect treatment comparison
Hankosky ER, He X, Malik R, et al.
Diabetes Obes Metab. Pub. online 5 May 2025.
Leggi